Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0R04
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,672
Award facts
- Contract value 100% obligated
- $5,672.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,672.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on January 15, 2026. This delivery order, issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract (IDC), authorizes DMS Pharmaceutical Group to supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The award carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group holds a single-award IDC valued at $499,999,999 with a completion date of December 31, 2036, positioning the company as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy.
DMS Pharmaceutical Group specializes in distributing a comprehensive portfolio of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide. The company's product offerings span multiple therapeutic categories, including oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. As a critical supplier within the federal pharmaceutical supply chain since its registration in the System for Award Management in 2001, DMS Pharmaceutical Group has demonstrated consistent contract performance through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with no identified subcontractor relationships in the award documentation.
Quick answers
Who was awarded contract SPE2DU26F0R04?
SPE2DU26F0R04 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DU26F0R04 worth?
The government has obligated $5,672 on SPE2DU26F0R04.
Is contract SPE2DU26F0R04 an order under another contract?
Yes. SPE2DU26F0R04 is a delivery order under SPE2DU25D9811, an indefinite delivery contract.
Was contract SPE2DU26F0R04 competed?
The extent of competition for SPE2DU26F0R04 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award